MyoSure NL

We’re an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. While we discover and develop groundbreaking products and services that benefit everyone, we are especially passionate about those that advance women’s health and well-being. This allows us to be a company that prospers, grows and empowers women to experience healthier lives.

None of this would be possible without the talent, skills and aspirations of our employees. Their expertise and dedication to developing and sharing more robust, science-based certainty drives our increasingly global presence, as well as a pipeline that responds to the unmet health and wellness needs of women, families and communities.

What powers our growth across Breast & Skeletal Health, Diagnostic Solutions, and GYN Surgical Solutions is also what differentiates us: the exceptional and clinically proven ability of our products to detect, diagnose and treat illnesses and other health conditions earlier and better. This clinical superiority creates high expectations, which we fulfill by always challenging ourselves to improve health through better technology, education and market access. Our goal is to minimize doubt and maximize the confidence our customers and their patients have in their decisions and diagnoses.

We work toward this goal every day, always aware that in an increasingly complex and competitive global environment, we must continually earn the trust of our customers and their patients. By focusing on women’s health while still delivering health benefits to everyone, we are setting a new standard of excellence that is strengthened by purpose, driven by passion and brought to life by our promise of more certain early detection and better health outcomes.  
To view our community guidelines, visit: www.hologic.com/social-media

Ascent Venture Partners

Hologic, Inc.

Reminder! Join Dr. Soyini Hawkins tomorrow, December 13 at 8 p.m. ET / 5 p.m. PT for an Acessa Patient Selection webinar.
Register now: https://bit.ly/3Qd17N6 #Hologic #FibroidAwareness

Join us at ASLM in Cape Town, South Africa from 12-15 December.

Find us at Booth 2, to meet our experts and learn more about our multi-disease testing capabilities and how our extensive portfolio of assays help you meet your lab's growing needs.
Our molecular testing portfolio is designed to bring clinical confidence and workflow efficiency to labs and clinicians whilst guiding patient care and enabling early detection. 

Are you attending?

We are proud to be recognized for the third consecutive year as one of America’s Most Responsible Companies by Newsweek! As a purpose-driven organization championing the health of women, their families and their communities, our employees work every day to be a global force for good. #WhyHologic https://ow.ly/lQV550QgYnr

Meet Gianluca, who is part of our diagnostics team in Italy. He explains how working at Hologic comes with a feeling of connection and belonging with his colleagues thanks to their shared dedication to enabling healthier lives. #WhyHologic

Our dedication to the fight against HIV and AIDS goes back to the 1990s when the National Heart, Lung, and Blood Institute (NHLBI) approached us to develop a nucleic acid blood screening test for the detection of HIV. Today, our cutting-edge HIV detection technology can help patients even more: https://bit.ly/49tsgDf #HIVAwarenessMonth

Join us on Monday, December 11th at 10am ET for “Access Across America: A Year-End Reflection on Women’s Health Policy.” This webinar hosted by our Director of Government Affairs Mia Keeys, will feature a panel of leading women’s health and policy experts reflecting on the developments of the past year and discussing what’s in store for 2024, with a special focus on rural and underserved communities across the United States. Register here: https://bit.ly/49YEV0W

IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

WordPress

LetsEncrypt

nginx

Chief Engineer, Lead Platform Architect

Adrian Hunsdon

Marketing and Product

Ani Zalidas

Corporate Counsel

Anne Liddy

Sales & Marketing Executive - Nordic

Anneli Edlund

Owner/Piano and Voice Instructor, Professional Musician

Barbara Taylor

Owner

Cathy Wimmer

Chris Jones

Chapter Owner, Director at Chat,Chew & Chocolate(Indianapolis Chapter)

Danita Smith

Chief Security Officer

Dick Parry

VP & Asst. General Counsel

Dru Greenhalgh

Christiana Stamoulis

Nancy G. Brinker

Elaine Ullian

Namal Nawana

Director

Jay Stein

Co-founder, Chairman Emeritus, Senior Vice President & Chief Technical Officer

Stephen MacMillan

Chairman, President & CEO

Scott Thiel

Head of Regulatory Policy and Intelligence

Stephen P. MacMillan

Chairman President & CEO

Thomas West

Division President, Diagnostics Solutions

Mohamed Yatim

Lead Design Assurance Engineer

Pierre Malboeuf

Senior National Director - Field Service

Massachusetts Public Companies With More Than $50M in Revenue

Health Diagnostics Companies With More Than $10M in Revenue

Northeastern US Companies that Exited (Top 10K)

Women's Companies

Hologic engages in developing, manufacturing, and supplying medical imaging systems and diagnostic and surgical products focused on the healthcare needs of women Products.

Post-IPO Equity - Hologic

Venture Round - Hologic

Marlborough

Massachusetts

United States

North America

Hologic

Hologic to lay off 86 employees during the last leg of Conn. facility closure

Hologic to close Connecticut facility, lay off 86 employees

Hologic to lay off 86 people in closure of Connecticut facility

Hologic to purchase California women’s health device manufacturer for $350M

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments

Hologic to acquire Gynesonics

Hologic announces $1.5B share repurchase program

Hologic posts 2.7% increase in revenue for Q3 2024

Belgium

Europe

United Kingdom

Costa Rica

Poland

HTML5

Cloudflare CDN

Facebook Comments

Modernizr

Adobe Fonts

Office 365

F5 NGINX

Bootstrap

Google Drive

Google Maps API

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 29, 2024 5:10 PM	cdbf9576
crunchbase profile	general	Oct 30, 2024 4:48 AM	3775c036
li profile	general	Feb 6, 2024 12:33 AM	12b2fb89
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	e032693e
peers	general	Feb 6, 2024 12:33 AM	1079ec82
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:HOLOGIC

Hologic

Last Close

78.04

21/11 21:00

Market Cap

17.68B

Beta: -

Volume Today

1.40M

Avg: -